Loading
Latest filing published 28 Sept 2026 for DarioHealth Corp.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Dennis M. Mcgrath span 4 companies, the busiest being DarioHealth Corp., Lucid Diagnostics Inc. and Citius Oncology, Inc. In total, 16 filings cover trades dated from 26 May 2021 to 24 September 2026.
No open-market purchase appears, only 2 sales worth €679k. Besides market trades, the filings include 14 share grants.
On 28 September 2026 came the latest disclosure, a share grant in DarioHealth Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations